Instrument Inactif

Transcripts Tetraphase Pharmaceuticals, Inc.

Actions

US88165N2045

Produits pharmaceutiques

Transcripts

12/11/19	Transcript : Tetraphase Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 12, 2019
08/08/19	Transcript : Tetraphase Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 08, 2019
20/05/19	Transcript : Tetraphase Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference 2019, May-20-2019 01:30 PM
08/05/19	Transcript : Tetraphase Pharmaceuticals, Inc., Q1 2019 Earnings Call, May 08, 2019
14/03/19	Transcript : Tetraphase Pharmaceuticals, Inc., Q4 2018 Earnings Call, Mar 14, 2019
08/11/18	Transcript : Tetraphase Pharmaceuticals, Inc., Q3 2018 Earnings Call, Nov 08, 2018
27/08/18	Transcript : Tetraphase Pharmaceuticals, Inc. - Special Call
21/05/18	Transcript : Tetraphase Pharmaceuticals, Inc. Presents at 2018 UBS Global Healthcare Conference, May-21-2018 01:00 PM
13/02/18	Transcript : Tetraphase Pharmaceuticals, Inc. - Special Call
25/07/17	Transcript : Tetraphase Pharmaceuticals, Inc. - Special Call
08/03/17	Transcript : Tetraphase Pharmaceuticals, Inc., Q4 2016 Earnings Call, Mar 08, 2017
23/02/16	Transcript : Tetraphase Pharmaceuticals, Inc., Q4 2015 Earnings Call, Feb 23, 2016
08/12/15	Transcript : Tetraphase Pharmaceuticals, Inc. Presents at 26th Annual Oppenheimer Healthcare Conference, Dec-08-2015 01:00 PM
17/11/15	Transcript : Tetraphase Pharmaceuticals, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 08:00 AM
08/09/15	Transcript : Tetraphase Pharmaceuticals, Inc. - Special Call
05/08/15	Transcript : Tetraphase Pharmaceuticals, Inc., Q2 2015 Earnings Call, Aug 05, 2015
06/05/15	Transcript : Tetraphase Pharmaceuticals, Inc., Q1 2015 Earnings Call, May 06, 2015
05/03/15	Transcript : Tetraphase Pharmaceuticals, Inc., Q4 2014 Earnings Call, Mar 05, 2015
09/02/15	Transcript : Tetraphase Pharmaceuticals, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 01:00 PM
17/12/14	Transcript : Tetraphase Pharmaceuticals, Inc. - Special Call
02/09/14	Transcript : Tetraphase Pharmaceuticals, Inc. - Special Call